中文摘要：

目的：分析穴位注射联合丹红注射液治疗对脊髓型颈椎病患者神经功能与生活质量的影响.方法：选取2014-01/2016-05河北省中医院骨伤一科收治的96例脊髓型颈椎病患者作为研究对象,将其随机分为对照组（n=48）和观察组（n=48）.对照组患者在脊髓型颈椎病常规基础治疗上予以丹红注射液治疗,观察组患者在对照组基础上联合穴位注射治疗.治疗结束后比较两组患者的神经功能评分、生活质量、临床疗效及治疗过程中不良反应的发生情况.结果：两组患者治疗后JOA评分和40分法评分均较治疗前升高,且观察组升高程度更为明显,差异具有统计学意义（P〈0.05）;治疗后观察组患者生活总质量评分高于对照组,差异具有统计学意义（P〈0.05）;两组患者不良反应发生率比较,差异无统计学意义（6.25%vs 10.42%）,且均无严重不良反应发生.结论：穴位注射联合丹红注射液可较好地恢复脊髓型颈椎病患者的神经功能,提高其生活质量,且在治疗过程中无明显严重不良反应,可作为临床治疗脊髓型颈椎病的有效治疗方案.

英文摘要：

AIM： To investigate the effect of point injection combined with Dan Hong Injection on the neurological function and life quality of patients with cervical spondylosis myelopathy. METHODS ： A total of 96 cases of cervical spondylotie myelopa- thy admitted into Hebei Provincial Hospital of Traditional Chinese Medicine from January 2014 to May 2016 were selected and ran- domly divided into control group and observation group with 48 ca- ses in each group. The patients in control group were treated by Danhong injection treatment based on cervical spondylotic myelop- athy routine treatment. The patients in observation group were treated by point injection based on control group therapy. The neu- rological function score, quality of life, clinical effect and adverse reaction were observed and compared between two groups. RESULTS： The JOA score and 40 points score were higher than those before treatment in two groups and increased degree in the observation group was more obvious with statistically significant differences （P〈0.05） ; After treatment, the total life quality score in the observation group was higher than that of the control group, with a statistically significant difference（P〈0.05） ; The incidence of adverse reactions had no significant difference between the two groups （6.25% vs 10.42%）, and there were no serious adverse reactions. CONCLUSION： The neurological function and life quality of patients with cervical spondylotic myelopathy can be improved by point injection combined with Danhong injection. No obvious adverse reactions happen in the course of treatment. The therapy can be used as the effective treatment for patients with cervical spondylotic myelopathy.